This Sunday, December 8, 2024, the team responsible for issuing Cyberpharmaceuticals tokens was pleasantly surprised during the operational tests on the Ethereum network.

Without any promotion beyond the company’s official website, we launched the test phase for token transactions and the associated smart contract. To our surprise, in less than five hours, eight investors had already acquired our tokens, demonstrating spontaneous interest and alignment with our company’s values.

The IT team and development specialists were thrilled and highly motivated by this unexpected response. This testing phase was designed solely to ensure operational readiness, and we did not anticipate any external participation beyond our internal team.

The Cyberpharmaceuticals team extends its heartfelt thanks to the first investors who embraced our vision and goals. We are excited to continue our work and are committed to keeping everyone informed about the project’s progress.

Welcome to our journey of innovation and progress in animal health!